Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Dec 8;82(1):98–103. doi: 10.1054/bjoc.1999.0884

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

G V Kornek 1, A Schratter-Sehn 2, A Marczell 4, D Depisch 5, J Karner 3, G Krauss 6, K Haider 5, W Kwasny 5, G Locker 1, W Scheithauer 1
PMCID: PMC2363209  PMID: 10638974

Abstract

The aim of the study was to evaluate the effectiveness and safety of a combined treatment modality including systemic chemotherapy with 5-fluorouracil (FU), leucovorin, cisplatin and external beam radiotherapy in patients with locally advanced pancreatic cancer. Systemic chemotherapy consisted of FU 400 mg m−2and leucovorin 20 mgm−2both given as intravenous bolus injection on days 1–4, plus cisplatin 20 mgm−2administered as 90-min infusion on days 1–4. Treatment courses were repeated every 4 weeks × 6 unless prior evidence of progressive disease. Radiation therapy using megavolt irradiation of ≥ 6 MV photons with a 3- or 4-field technique was delivered during the second and third chemotherapy course, that was reduced in dose by 25%. Between October 1994 and July 1996, a total of 38 patients were entered onto this trial, all of whom were assessable for toxicity and survival. Eighteen of these (47%) had objective remissions to combined radiochemotherapy, including four CR (11%), 13 (34%) had stable disease and seven patients (18%) showed tumour progression during treatment. The median progression-free interval of the entire study population was 10 months (range 3–32), and median overall survival was 14.0 months (range 3–45+ months); 53% of all patients were alive at 12 months, and 18% of patients were alive at 24 months respectively. Severe haematological side-effects comprised neutropenia in 18%, thrombocytopenia in 8% and anaemia in 11%. The most frequent non-haematological side-effects were nausea/vomiting (WHO grade 3: 18%), and diarrhoea (grade 3: 13%). This combined radiochemotherapy regimen was tolerable and effective in patients with locally advanced pancreatic cancer. Since therapeutic results, in fact, compare favourably with other series, including surgical treatment of potentially resectable tumours, further evaluation of combined treatment modalities in the neoadjuvant setting seems warranted. © 2000 Cancer Research Campaign

Keywords: pancreatic cancer; neoadjuvant; chemoradiation; cisplatin; 5-fluorouracil, leucovorin

Full Text

The Full Text of this article is available as a PDF (76.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. André T., Lotz J. P., Bouleuc C., Azzouzi K., Houry S., Hannoun L., See J., Esteso A., Avenin D., Izrael V. Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma. Ann Oncol. 1996 Feb;7(2):173–178. doi: 10.1093/oxfordjournals.annonc.a010545. [DOI] [PubMed] [Google Scholar]
  2. Bruckner H. W., Crown J., McKenna A., Hart R. Leucovorin and 5-fluorouracil as a treatment for disseminated cancer of the pancreas and unknown primary tumors. Cancer Res. 1988 Oct 1;48(19):5570–5572. [PubMed] [Google Scholar]
  3. Crown J., Casper E. S., Botet J., Murray P., Kelsen D. P. Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. J Clin Oncol. 1991 Sep;9(9):1682–1686. doi: 10.1200/JCO.1991.9.9.1682. [DOI] [PubMed] [Google Scholar]
  4. Dreyfuss A. I., Clark J. R., Wright J. E., Norris C. M., Jr, Busse P. M., Lucarini J. W., Fallon B. G., Casey D., Andersen J. W., Klein R. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med. 1990 Feb 1;112(3):167–172. doi: 10.7326/0003-4819-112-3-167. [DOI] [PubMed] [Google Scholar]
  5. Forastiere A. A., Orringer M. B., Perez-Tamayo C., Urba S. G., Husted S., Takasugi B. J., Zahurak M. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol. 1990 Jan;8(1):119–127. doi: 10.1200/JCO.1990.8.1.119. [DOI] [PubMed] [Google Scholar]
  6. Gralla R. J. Preoperative and adjuvant chemotherapy in non-small cell lung cancer. Semin Oncol. 1988 Dec;15(6 Suppl 7):8–12. [PubMed] [Google Scholar]
  7. Griffin J. F., Smalley S. R., Jewell W., Paradelo J. C., Reymond R. D., Hassanein R. E., Evans R. G. Patterns of failure after curative resection of pancreatic carcinoma. Cancer. 1990 Jul 1;66(1):56–61. doi: 10.1002/1097-0142(19900701)66:1<56::aid-cncr2820660112>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  8. Gudjonsson B. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg. 1995 Dec;181(6):483–503. [PubMed] [Google Scholar]
  9. Hoffman J. P., Lipsitz S., Pisansky T., Weese J. L., Solin L., Benson A. B., 3rd Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol. 1998 Jan;16(1):317–323. doi: 10.1200/JCO.1998.16.1.317. [DOI] [PubMed] [Google Scholar]
  10. Kamthan A. G., Morris J. C., Dalton J., Mandeli J. P., Chesser M. R., Leben D., Cooperman A., Bruckner H. W. Combined modality therapy for stage II and stage III pancreatic carcinoma. J Clin Oncol. 1997 Aug;15(8):2920–2927. doi: 10.1200/JCO.1997.15.8.2920. [DOI] [PubMed] [Google Scholar]
  11. Klaassen D. J., MacIntyre J. M., Catton G. E., Engstrom P. F., Moertel C. G. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. J Clin Oncol. 1985 Mar;3(3):373–378. doi: 10.1200/JCO.1985.3.3.373. [DOI] [PubMed] [Google Scholar]
  12. Komaki R., Wadler S., Peters T., Byhardt R. W., Order S., Gallagher M. J., Herskovic A., Pederson J. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801). Cancer. 1992 Jun 1;69(11):2807–2812. doi: 10.1002/1097-0142(19920601)69:11<2807::aid-cncr2820691128>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  13. Moertel C. G., Frytak S., Hahn R. G., O'Connell M. J., Reitemeier R. J., Rubin J., Schutt A. J., Weiland L. H., Childs D. S., Holbrook M. A. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer. 1981 Oct 15;48(8):1705–1710. doi: 10.1002/1097-0142(19811015)48:8<1705::aid-cncr2820480803>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  14. Moertel C. G., Gunderson L. L., Mailliard J. A., McKenna P. J., Martenson J. A., Jr, Burch P. A., Cha S. S. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. J Clin Oncol. 1994 Jan;12(1):21–27. doi: 10.1200/JCO.1994.12.1.21. [DOI] [PubMed] [Google Scholar]
  15. Mohiuddin M., Regine W. F., Stevens J., Rosato F., Barbot D., Biermann W., Cantor R. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol. 1995 Nov;13(11):2764–2768. doi: 10.1200/JCO.1995.13.11.2764. [DOI] [PubMed] [Google Scholar]
  16. Nagai H., Kuroda A., Morioka Y. Lymphatic and local spread of T1 and T2 pancreatic cancer. A study of autopsy material. Ann Surg. 1986 Jul;204(1):65–71. doi: 10.1097/00000658-198607000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nicolson M., Webb A., Cunningham D., Norman A., O'Brien M., Hill A., Hickish T. Cisplatin and protracted venous infusion 5-fluorouracil (CF)--good symptom relief with low toxicity in advanced pancreatic carcinoma. Ann Oncol. 1995 Oct;6(8):801–804. doi: 10.1093/oxfordjournals.annonc.a059319. [DOI] [PubMed] [Google Scholar]
  18. Parker S. L., Tong T., Bolden S., Wingo P. A. Cancer statistics, 1996. CA Cancer J Clin. 1996 Jan-Feb;46(1):5–27. doi: 10.3322/canjclin.46.1.5. [DOI] [PubMed] [Google Scholar]
  19. Popescu R. A., Cunningham D. Chemotherapy for advanced pancreatic cancer--some light at the end of the tunnel? Ann Oncol. 1997 May;8(5):415–416. doi: 10.1023/a:1008292224326. [DOI] [PubMed] [Google Scholar]
  20. Prott F. J., Schönekaes K., Preusser P., Ostkamp K., Wagner W., Micke O., Pötter R., Sulkowski U., Rübe C., Berns T. Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study. Br J Cancer. 1997;75(4):597–601. doi: 10.1038/bjc.1997.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rothman H., Cantrell J. E., Jr, Lokich J., Difino S., Harvey J., Ahlgren J., Fryer J. Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. A Mid-Atlantic Oncology Program study. Cancer. 1991 Jul 15;68(2):264–268. doi: 10.1002/1097-0142(19910715)68:2<264::aid-cncr2820680208>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  22. Scheithauer W., Depisch D., Kornek G., Pidlich J., Rosen H., Karall M., Prochaska M., Ernst A., Sebesta C., Eckhardt S. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer. Cancer. 1994 Mar 15;73(6):1562–1568. doi: 10.1002/1097-0142(19940315)73:6<1562::aid-cncr2820730606>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  23. Schnall S. F., Macdonald J. S. Chemotherapy of adenocarcinoma of the pancreas. Semin Oncol. 1996 Apr;23(2):220–228. [PubMed] [Google Scholar]
  24. Spitz F. R., Abbruzzese J. L., Lee J. E., Pisters P. W., Lowy A. M., Fenoglio C. J., Cleary K. R., Janjan N. A., Goswitz M. S., Rich T. A. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 1997 Mar;15(3):928–937. doi: 10.1200/JCO.1997.15.3.928. [DOI] [PubMed] [Google Scholar]
  25. Tepper J., Nardi G., Sutt H. Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy. Cancer. 1976 Mar;37(3):1519–1524. doi: 10.1002/1097-0142(197603)37:3<1519::aid-cncr2820370340>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  26. Vokes E. E., Weichselbaum R. R., Mick R., McEvilly J. M., Haraf D. J., Panje W. R. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst. 1992 Jun 3;84(11):877–882. doi: 10.1093/jnci/84.11.877. [DOI] [PubMed] [Google Scholar]
  27. Warshaw A. L., Fernández-del Castillo C. Pancreatic carcinoma. N Engl J Med. 1992 Feb 13;326(7):455–465. doi: 10.1056/NEJM199202133260706. [DOI] [PubMed] [Google Scholar]
  28. Weinerman B. H., MacCormick R. E. A phase II survival comparison of patients with adenocarcinoma of the pancreas treated with 5-fluorouracil and calcium leucovorin versus a matched tumor registry control population. Am J Clin Oncol. 1994 Dec;17(6):467–469. doi: 10.1097/00000421-199412000-00002. [DOI] [PubMed] [Google Scholar]
  29. Willett C. G., Lewandrowski K., Warshaw A. L., Efird J., Compton C. C. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg. 1993 Feb;217(2):144–148. doi: 10.1097/00000658-199302000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yeo C. J., Cameron J. L., Lillemoe K. D., Sitzmann J. V., Hruban R. H., Goodman S. N., Dooley W. C., Coleman J., Pitt H. A. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995 Jun;221(6):721–733. doi: 10.1097/00000658-199506000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yeung R. S., Weese J. L., Hoffman J. P., Solin L. J., Paul A. R., Engstrom P. F., Litwin S., Kowalyshyn M. J., Eisenberg B. L. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study. Cancer. 1993 Oct 1;72(7):2124–2133. doi: 10.1002/1097-0142(19931001)72:7<2124::aid-cncr2820720711>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES